학술논문
566P A multicenter, open-label, dose-escalation, first-in-man study of MetAP2 inhibitor M8891 in patients with advanced solid tumours
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S486-S486
Subject
Language
ISSN
0923-7534